Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

12,958 total articles

3 E Network CEO Outlines Strategic Vision for Robotics, Highlighting Silicon Innovation and Edge AI

3 E Network CEO Outlines Strategic Vision for Robotics, Highlighting Silicon Innovation and Edge AI

3 E Network Technology Group Limited, a Nasdaq-listed B2B IT business solutions provider, announced its strategic roadmap to become a next-generation AI infrastructure provider focusing on robotics. CEO Dr. Tingjun Yang emphasized advancing edge AI through silicon hardware innovation, hardware-software co-design, and building a scalable computing p…

Scilex Holding Company (“Scilex”) Confirms the Previously Announced Payment Date of June 15, 2026 for the Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities

Scilex Holding Company (“Scilex”) Confirms the Previously Announced Payment Date of June 15, 2026 for the Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities

Scilex Holding Company (Nasdaq: SCLX), a US-based biopharmaceutical company specializing in non-opioid pain management products, has confirmed the payment date of June 15, 2026, for a dividend of Semnur Pharmaceuticals, Inc. (OTC: SMNR) common stock to its shareholders. Eligible holders as of June 1, 2026, will receive one share of Semnur common st…

United Community Banks, Inc. Announces Agreement to Sell Equipment Finance Business, Consisting of Navitas Credit Corp. and NLFC Reinsurance Corp., to Funds Managed by Wafra Inc.

United Community Banks, Inc. Announces Agreement to Sell Equipment Finance Business, Consisting of Navitas Credit Corp. and NLFC Reinsurance Corp., to Funds Managed by Wafra Inc.

United Community Banks, Inc. announced a definitive agreement to sell its equipment finance business, Navitas Credit Corp. and NLFC Reinsurance Corp., to funds managed by Wafra Inc. for $1.9 billion in cash. The transaction is expected to enhance United's liquidity and capital strength, reduce risk in its loan portfolio, and allow greater focus on …

Fervo Energy to Report First Quarter 2026 Results on June 22, 2026

Fervo Energy to Report First Quarter 2026 Results on June 22, 2026

Fervo Energy, a NASDAQ-listed independent power producer specializing in Enhanced Geothermal Systems, will report its first quarter 2026 financial and operational results on June 22, 2026, with a webcast and conference call scheduled to discuss the details. The company emphasizes its role in advancing clean, reliable geothermal energy to meet incre…

Village Farms Launches Pure Sunfarms Pink Kush Cured Resin Vape

Village Farms Launches Pure Sunfarms Pink Kush Cured Resin Vape

Village Farms International, Inc. announces the launch of the Pure Sunfarms Pink Kush Cured Resin 510 Vape in Canada, extending their top-selling Pink Kush strain into the rapidly expanding vape segment. The product offers a true-to-flower experience with premium cured resin, aiming to capture growth in the Canadian cannabis vape market, which is t…

MBX Biosciences Announces One-Year Data Demonstrating Sustained Benefit of Once-Weekly Canvuparatide as a Potential PTH Replacement Therapy in Chronic Hypoparathyroidism

MBX Biosciences Announces One-Year Data Demonstrating Sustained Benefit of Once-Weekly Canvuparatide as a Potential PTH Replacement Therapy in Chronic Hypoparathyroidism

MBX Biosciences released one-year data from its ongoing open-label extension study of once-weekly canvuparatide in chronic hypoparathyroidism patients, showing sustained responder rates, normalization of calcium levels, improved kidney function, and bone metabolism restoration with good tolerance. The Phase 3 trial initiation is on track for Q3 202…

Kymera Therapeutics Presents Phase 1 Data in Healthy Japanese Adults for KT-621, a First-in-Class Oral STAT6 Degrader, at the Japanese Dermatological Association Annual Meeting

Kymera Therapeutics Presents Phase 1 Data in Healthy Japanese Adults for KT-621, a First-in-Class Oral STAT6 Degrader, at the Japanese Dermatological Association Annual Meeting

Kymera Therapeutics announced Phase 1 clinical results for KT-621, its first-in-class oral STAT6 degrader, presented at the Japanese Dermatological Association meeting. The study in healthy Japanese adults showed favorable safety, pharmacokinetics, and strong STAT6 degradation consistent with previous data. Parallel Phase 2b trials in atopic dermat…

BioCryst Presents New Clinical Data and Real-World Evidence Demonstrating Impact of HAE Portfolio at the 2026 European Academy of Allergy and Clinical Immunology Annual Meeting

BioCryst Presents New Clinical Data and Real-World Evidence Demonstrating Impact of HAE Portfolio at the 2026 European Academy of Allergy and Clinical Immunology Annual Meeting

BioCryst Pharmaceuticals presented new clinical and real-world evidence highlighting the effectiveness of its hereditary angioedema (HAE) portfolio, including ORLADEYO, an oral prophylactic treatment, and investigational monoclonal antibody navenibart. Data demonstrated sustained reductions in HAE attack rates, healthcare utilization, and positive …

Announcement of EGM Results

Announcement of EGM Results

Kaspi.kz held an Extraordinary General Meeting where shareholders approved a dividend payment of 850 tenge per common share for Q1 2026, with payments commencing on June 11, 2026. Additionally, the company appointed three members to its Counting commission with unlimited terms.

Medallion Bank Announces CEO Transition

Medallion Bank Announces CEO Transition

Medallion Bank, a US-based FDIC-insured industrial bank and subsidiary of Medallion Financial Corp., announced the retirement of CEO Donald Poulton effective June 30, 2026. Justin Haley, promoted to President earlier this year, will become CEO starting July 1, 2026. Poulton will remain on the Board and chair the Risk Committee, ensuring continuity …

Rocket Lab To Join The Nasdaq-100 Index

Rocket Lab To Join The Nasdaq-100 Index

Rocket Lab Corporation (Nasdaq: RKLB), a prominent launch services and space systems company, will be included in the Nasdaq-100 Index effective June 22, 2026. This inclusion recognizes Rocket Lab as one of the largest non-financial companies on Nasdaq, underscoring its rapid growth and significant role in commercial, civil, and national security s…

Aurora Mobile MoonFox Data | iQIYI’s 2025 Revenue Continues to Decline, 2026 Accelerates Innovation to Break Through

Aurora Mobile MoonFox Data | iQIYI’s 2025 Revenue Continues to Decline, 2026 Accelerates Innovation to Break Through

iQIYI reported a revenue decline of 7% in 2025, ending its profitability cycle, but Q4 showed notable recovery with 3% revenue growth and 13% ARPU increase. The company is leveraging hit content, AI technology, and overseas market expansion to overcome industry challenges and improve monetization, with plans including a Hong Kong secondary listing …

Autolus Therapeutics Receives Prix Galien UK Award

Autolus Therapeutics Receives Prix Galien UK Award

Autolus Therapeutics, a Nasdaq-listed commercial-stage biopharmaceutical company specializing in next-generation programmed T cell therapies, has been awarded the 2026 Prix Galien UK Award for Best Biotechnology Product. This accolade recognizes their innovative contributions to biotechnology and patient care, affirming the company's scientific lea…

Evaxion receives Prix Galien UK Award for Best digital health solution

Evaxion receives Prix Galien UK Award for Best digital health solution

Evaxion A/S, a clinical-stage TechBio company listed on NASDAQ, received the 2026 Prix Galien UK Award for Best Digital Health Solution for its AI-Immunology™ platform. The award highlights the platform's innovation in decoding the human immune system to develop vaccine candidates for cancer and infectious diseases. This recognition underscores the…

CBAK Energy Showcases Cylindrical Battery Solutions for Europe’s Expanding Energy Storage Market at The Battery Show Europe 2026

CBAK Energy Showcases Cylindrical Battery Solutions for Europe’s Expanding Energy Storage Market at The Battery Show Europe 2026

CBAK Energy showcased its latest cylindrical lithium-ion and sodium-ion battery technologies at The Battery Show Europe 2026, emphasizing safety certifications, long lifecycle, and reliable performance tailored to Europe's growing portable and residential energy storage market. The company also introduced a new high-power battery designed for AI da…

Nova Minerals Announces NYSE American Listing Approval

Nova Minerals Announces NYSE American Listing Approval

Nova Minerals Corp announced the approval of its common stock and warrants for listing on the NYSE American exchange under ticker symbols NVA and NVAWS respectively, with trading expected to begin around June 17, 2026. This listing is a significant step toward advancing the Estelle Gold and Critical Minerals project focused on domestic production o…

HF Foods Adopts Limited Duration Stockholder Rights Plan

HF Foods Adopts Limited Duration Stockholder Rights Plan

HF Foods Group Inc. announced the adoption of a limited duration stockholder rights plan in response to credible indications of undisclosed stock accumulation aimed at gaining control of the company. The plan is designed to protect stockholder interests by preventing any entity or group from acquiring 15% or more of outstanding shares without board…

Skyworks Announces Results of Early Participation in Exchange Offers and Consent Solicitations for Qorvo’s Senior Notes due 2029 and 2031

Skyworks Announces Results of Early Participation in Exchange Offers and Consent Solicitations for Qorvo’s Senior Notes due 2029 and 2031

Skyworks Solutions, Inc. reported high early participation levels in its exchange offers and consent solicitations for Qorvo's senior notes due 2029 and 2031. These actions are part of preparations for the proposed merger whereby Qorvo will become a wholly owned subsidiary of Skyworks. The consent solicitations seek approval for amendments that rem…

HUTCHMED Highlights Sovleplenib ESLIM-02 Phase III Data in Warm Antibody Autoimmune Hemolytic Anemia Presented at EHA 2026 Congress

HUTCHMED Highlights Sovleplenib ESLIM-02 Phase III Data in Warm Antibody Autoimmune Hemolytic Anemia Presented at EHA 2026 Congress

HUTCHMED announced positive results from the Phase III ESLIM-02 trial of Sovleplenib, a novel Syk inhibitor, in patients with warm antibody autoimmune hemolytic anemia (wAIHA) in China. The study met its primary endpoint with a significantly higher durable hemoglobin response compared to placebo, demonstrating rapid efficacy and reduced need for re…